 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.

Slides:



Advertisements
Similar presentations
The PARticulars of Parkinson’s Disease
Advertisements

An Overview of Conventional and Experimental Treatments
Knowledge and Attitudes Toward Genetic Testing in Parkinson’s Disease Dana Lundberg 2006.
Parkinson’s Disease Shirley H. Wray, M.D., Ph.D., Professor of Neurology, Harvard Medical School Director, Unit for Neurovisual Disorders Massachusetts.
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
Is it a neurodegenerative brain disorder that progresses slowly in most people.
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Parkinson’s Disease By Devin Cornford
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative.
SYMPTOM CONTROL IN ADVANCED PARKINSON’S DISEASE Vicky Travers PDNSUHMBT April 2012.
Duodenal Levodopa Treatment in advanced Parkinson’s Disease
Parkinson’s Disease. Definition Parkinson's disease (PD) is an idiopathic, slowly progressive, neurodegenerative disorder whereby two or more of the following.
Parkinson’s Disease superKAT :).
Joohi Jimenez-Shahed, MD Assistant Professor of Neurology Baylor College of Medicine 8 th Annual IMHO Convention April 30, 2011 – Houston, TX Parkinson’s.
Surgery for Parkinson’s Disease: Focus on Deep Brain Stimulation Ramón L Rodríguez, MD Director of Clinical Services University of Florida Movement Disorders.
BY: MACKENZIE SOARES ALYSSA MEDIEROS STEPHANIE GARDNER Parkinson's Disease.
PARKINSON’S DISEASE By Courtney and Niral. WHAT IS IT?  Parkinson's disease (PD) is chronic and progressive movement disorder, meaning that symptoms.
Innovations in Parkinson’s Diagnosis & Treatment: A Personal Story Dr. Kenneth E. Keirstead Excellence in Aging Care Symposium September 25-27, 2013.
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Salvador Dali (Painter) Mao Zedong (Chinese Politician) Michael J Fox (Actor) Pope John Paul II Muhammad Ali (Boxer) Janet Reno (Former AG)
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
Temporal Enhancement of Motor Control in Parkinson’s Disease patients Marta Bieńkiewicz PhD Student Queen’s University Belfast.
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Chris Kao Project Team: Kylen Bares Eddie Cao.
 Parkinson Disease (PD) is a disorder of the brain that causes a variety of movement problems.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
PARKINSON’S DISEASE BY: NICOLE MABARDI & SHAINA JOSEPH.
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Anita Mahadevan-Jansen Faraz Ali James Lugge Ernest Moore Mahesh Parlikad.
Parkinson's disease Carlo Varas. Definition progressive disorder of the nervous system that affects movement. tremor may be the most well-known sign of.
By: Alejandro Navarro and Andrea Ors. Content Introduction What is Parkinson's disease? What causes the disease? History Main symptoms Treatment Statistics.
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Anita Mahadevan-Jansen Faraz Ali James Lugge Ernest Moore Mahesh Parlikad.
Neurological Disorders
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
By Katelyn Chaimson and Sean Guyot
The organization of the nervous system. Structure of the human cerebral cortex.
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Parkinson's disease By Colby Allen. symptoms Mild to major tremors. Rigidity or joint stiffness Bradykinesia or slowness of movement Postural instability.
Parkinson’s Disease Sheila Mulhern. Parkinson’s Disease Stats (PDF)  One million Americans live with Parkinson's disease, - more than the combined number.
 Parkinson Disease (PD) is a progressive disorder of the central nervous system that often impairs the sufferer's motor skills, speech, and other functions.
PARKINSON’S DISEASE Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine.
Pathogenesis and pathology of parkinsonism
By Seamus Hogan.  Parkinsons disease is degenerative disorder of the central nervous system. it causes the dopamine to contain cells in the substantial.
PARKINSON’S ADAM KREAMER. WHAT IS PARKINSON’S? *Parkinson’s disease, also called PD, is categorized as a motor system disorder, which is a result of the.
Emma Hahs, Brooke Armistead, Sarah Brown, Sok Kean Khoo Department of Cell and Molecular Biology, College of Liberal Arts and Sciences, Grand Valley State.
Parkinson Disease An Overview including Community Resources Presented by Christy Prezyna, PT Ellen Tomer, LMSW Members of HCR’s Parkinson’s Program.
Reflections on animal models of neurological disorders Marie-Francoise Chesselet UCLA
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Anita Mahadevan-Jansen Faraz Ali James Lugge Ernest Moore Mahesh Parlikad.
PARKINSON’S DISEASE CHAMINDA UNANTENNE RN,MS,MSN.
Direct motor pathway Corticospinal pathway. Motor Units – Large Versus Small Text Fig
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
Direct motor pathway Corticospinal pathway.
Drugs Used for Parkinson’s Disease
Parkinson’s Disease.
Understanding Parkinsons Disease
Drugs for Parkinson’s Disease
Falon Fiorillo & Breeanna Fournier
Parkinson's disease KRZYSZTOF NICPOŃ.
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Parkinson's disease Parkinson's disease (PD) is the second-most common
Long Term Effects of Concussions
Quantitative Detection of Parkinson's Disease Symptoms
Parkinson’s Common neurodegenerative disorder ~10-20/1000
Quantitative Detection of Parkinson's Disease Symptoms
Basal ganglia function
Neurodegenerative diseases
HOW DOES EXPERIENCE AFFECT BEHAVIOUR AND MENTAL PROCESSES?
Presentation transcript:

 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults

 Population at risk: Male> Female Two types 1) yrs. of age (young onset) Michael J. Fox at age 30 2) yrs. of age (idiopathic) over 1 million affected in US with 50, ,000 new cases each year

 Genetics- only about 5%  Environmental factors -rural living -well water -pesticides/herbicides  Age

Presence of motor dysfunction with 4 cardinal symptoms  resting tremor  akinesia (slowness of body movement)  rigidity  Postural instability NO PREVENTION, NO CURE

 Degeneration of dopamine-producing neurons in the substantia nigra of the midbrain › Disrupts the balance of:  dopamine (DA) – neurotransmitter for normal functioning of the extrapyramidal motor system  Acetylcholine (Ach)  Symptoms do not occur until 80% of the neurons in the substantia nigra are lost

 Fatigue  Problems with manual dexterity  Slight tremor  Rigidity  Changes in facial expression  Uncontrolled drooling

 Dementia  Dysphagia  Excessive perspiration  Orthostatic hypotension  No specific diagnostic tests